Tuberculosis remains an unresolved public health problem in developing and industrialized countries, accounting for three million deaths annually worldwide (29) . Understanding its pathogenesis is therefore of paramount importance, heightened particularly by the recent increase in cases associated with the pandemic of human immunodeficiency virus infection (16) . In view of the essential roles played by mononuclear phagocytes in mycobacterial disease and the effects that cytokines have in granuloma formation and immunoregulatory and effector functions, it is important to understand the influence of unique mycobacterial products on cytokine expression.
In this regard, it has been shown, for example, that both Mycobacterium tuberculosis-derived purified protein derivative (PPD) and antigen 5, a partially purified cytoplasmic antigen, induce interleukin-1 (IL-1) from human monocytes (34) . Similarly, whole organisms of Mycobacterium bovis, culture filtrates of M. tuberculosis H37Ra, PPD, and antigen 5 all induced production of tumor necrosis factor alpha (TNF-␣) from human monocytes and alveolar macrophages (33) . Furthermore, a 30-kDa fibronectin-binding protein of M. tuberculosis (3) and a 58-kDa antigen in virulent M. tuberculosis culture filtrate (35) have been shown to induce TNF-␣. We have recently shown that M. tuberculosis (17) and its PPD (32) also induce the deactivating cytokine transforming growth factor ␤ (TGF-␤).
The expression of cytokines such as TNF-␣ and IL-1 in response to mycobacterial products is of interest because they are likely to mediate, at least in part, the pathogenesis and clinical manifestations of mycobacterial diseases. In a murine model, TNF-␣ was shown to have an essential role in the formation and maintenance of granuloma and in the elimination of mycobacteria following M. bovis BCG infection (21) . Other investigators have demonstrated that TNF-␣, when added to infected human monocyte-derived macrophages, augmented intracellular killing of Mycobacterium avium in a dosedependent manner (7) . Both TNF-␣ and gamma interferon decreased and TGF-␤ increased the intracellular multiplication of M. tuberculosis in human monocytes (17) . Several groups have shown increased TNF-␣ production in skin biopsies and in peripheral blood mononuclear cells (PBMC) of patients with the immunologically reactive localized (tuberculoid) form of leprosy (1, 5) . TNF-␣ has also been localized to pleural mononuclear cells of patients with the generally selfcontained pleural infection associated with M. tuberculosis (6) . On the other hand, TGF-␤ is produced by monocytes of patients with active tuberculosis and is present in tuberculous granulomatous lung lesions of such patients (30) .
With this in mind, attention has turned recently to a highly immunogenic surface lipoglycan of mycobacteria known as lipoarabinomannan (LAM). This lipoglycan accounts for up to 5 mg/g of bacterial weight and has been highly purified from Mycobacterium leprae and M. tuberculosis (19) . LAM consists of a mannan core with oligoarabinosyl-containing side chains, which is attached to a phosphatidylinositol anchor at one end (11, 18) . LAM has been studied most extensively in murine cells; LAM interferes with gamma interferon-mediated activation of macrophages (10, 28) , scavenges toxic oxygen free radicals, inhibits protein kinase C activity (10) , and induces the expression of macrophage immediate-early genes (26) . LAM has also been shown to induce several cytokines, especially TNF-␣, in both murine and human mononuclear phagocytes (4, 13) . Some studies have concluded that LAM is the main TNF-inducing component present in whole mycobacteria and preparations thereof, such as PPD.
Two major classes of LAM have been isolated from mycobacteria to date (25) ; LAM (ManLAM) from the virulent Erdman strain (12) , both the virulent H37Rv and the avirulent H37Ra strains, several other pathogenic mycobacteria, and BCG (25) is characterized by extensive mannose capping of the arabinan termini. In contrast, the arabinan termini of LAM from a rapidly growing laboratory strain of mycobacteria (AraLAM) is not mannosylated (12) . Interestingly, AraLAM was shown to induce up to 100-fold more TNF-␣ in murine macrophages than ManLAM. This marked biologic difference in activity has been attributed to the heavy mannose capping of ManLAM. Other studies have shown that the phosphatidylinositol anchor, similar between the two LAMs, is partly (13) or wholly (4) responsible for the biologic activity of LAM.
Therefore, in view of the central role which TNF-␣ appears to play in the immune response to M. tuberculosis and data suggesting that ManLAM induced less TNF-␣ in mouse macrophages than AraLAM, we believed that it was important to see if the latter observations could be extended to human monocytes and whether differential induction of cytokines by the two LAMs included the deactivating cytokines TGF-␤ and IL-10. We found that LAM from virulent M. tuberculosis was a poor inducer of the proinflammatory cytokines TNF-␣, IL-1, and IL-6. In contrast, AraLAM and PPD were potent inducers of these cytokines. Both LAMs were poor inducers of the anti-inflammatory cytokine IL-10 but were similar in induction of TGF-␤. Also, LAM from M. tuberculosis failed to modulate the activation of human monocytes by other stimuli.
MATERIALS AND METHODS
Isolation of primary human monocytes. Heparinized whole blood (20 U/ml) was obtained by venipuncture from healthy, tuberculin skin test-nonreactive donors. PBMC were separated by sedimentation through Ficoll-Paque (Pharmacia Fine Chemicals, Piscataway, N.J.) (8) . Monocytes were prepared by suspending PBMC (5 ϫ 10 6 /ml) in RPMI 1640 medium (BioWhittaker, Walkersville, Md.) supplemented with 2 mM L-glutamine and 25 mM HEPES (N-2-hydroxyethylpiperazine-NЈ-2-ethanesulfonic acid) buffer and incubated for 1 h at 37ЊC on plastic petri dishes (100 by 20 mm; Falcon, Oxnard, Calif.) which had been coated with 1.5 ml of pooled human serum (PHS). After removal of the nonadherent cells, the adherent monolayers were dislodged gently with a Teflon scraper, and the cells were counted. The adherent cell population consisted of 85 to 90% monocytes by peroxidase staining (20) and was 99% viable by trypan blue staining.
For RNA studies, monocytes were resuspended (2 ϫ 10 6 /ml) in RPMI with 2% (vol/vol) PHS in petri dishes (100 by 20 mm; Falcon) and incubated at 37ЊC with 5% CO 2 . At specified points after the addition of stimuli, total cellular RNA was obtained as described below. To generate cytokines, monocytes (10 6 /ml) in medium containing 2% (vol/vol) PHS were added to petri dishes (35 by 10 mm; Falcon), and cell supernatants were collected and kept at Ϫ20ЊC. In some experiments, cell lysates were prepared by addition of 0.5 ml of sterile water to plates, followed by three cycles of freeze-thawing and final reconstitution with 0.5 ml of phosphate-buffered saline (PBS) and 4% (vol/vol) PHS before storage.
Reagents. Lipopolysaccharide (LPS) derived from Escherichia coli F583 (Sigma) was dissolved in RPMI and kept frozen at Ϫ20ЊC. Prior to use, the stock was thawed and vortexed vigorously for 5 min. PPD of M. tuberculosis was a gift from Lederle Laboratories (American Cyanamid, Inc., Wayne, N.J.). ManLAM from the virulent strains of M. tuberculosis Erdman and H37Rv and AraLAM from a rapidly growing laboratory strain of mycobacterium were provided by Patrick Brennan (Colorado State University, Ft. Collins). Details of the extraction procedure and structures of the molecules have been published elsewhere (12, 18, 19) . Each preparation was passed over a Detoxigel column to deplete endotoxin contamination (19) . The endotoxin content of all reagents was measured in a chromogenic Limulus lysate assay (BioWhittaker). The two LAM preparations contained insignificant amounts of endotoxin (Ͻ20 pg/mg). PPD had 16 ng of endotoxin per mg of protein. The LAM content of PPD was assessed by Western immunoblot analysis with monoclonal antibody to LAM (CS-35), which recognizes LAMs from all strains of M. tuberculosis (25) , and was found to be less than 1 g/100 g of PPD.
Isolation and analysis of total cellular RNA. Total cellular RNA was isolated by the guanidinium cesium method (31) . RNA (5 to 10 g) was electrophoresed through 0.8% agarose-2 M formaldehyde gels and transferred to nylon membranes (Magnagraph; Micron Separations, Inc.). Membranes were baked for 1 h at 80ЊC and prehybridized for at least 5 h in 1% fatty acid-free bovine serum albumin (BSA; Sigma)-0.2 M sodium phosphate (pH 7.2)-3.75 M formamide-0.001 M EDTA-7% sodium dodecyl sulfate (SDS). [ 32 P]dCTP cDNA probes were prepared by random priming and added directly to the prehybridization solution at 10 6 cpm/ml, and the membranes were incubated overnight in a shaking water bath at 65ЊC. Membranes were washed once in 2ϫ SSC-2% SDS for 30 min at 50ЊC and twice in 0.2ϫ SSC-0.2% SDS for 30 min at 50 and 65ЊC successively (1ϫ SSC is 0.15 M NaCl plus 0.015 M sodium citrate).
Probes were generated from plasmid preparations made per the instructions provided with a kit (Qiagen, Chatsworth, Calif.) and included the following: (i) a 370-bp BamHI-HindIII fragment from the human TNF-␣ clone pAW783; (ii) a 550-bp BamHI-NdeI fragment from the human IL-1␤ plasmid p⌬11; (iii) a 1,200-bp EcoRI fragment from the human IL-6 plasmid pXM309; (iv) a 760-bp BglII-HindIII fragment from the human IL-10 plasmid pCDSR␣, provided by Kevin Moore (DNAX Research Institute, Palo Alto, Calif.); and (v) a 2,000-bp EcoRI fragment from the human TGF-␤ plasmid (J. Bell, University of Illinois). To assess equal loading of RNA, membranes were stripped and reprobed with a riboprobe for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (American Type Culture Collection).
Cytokine assays. Enzyme-linked immunosorbent assays (ELISAs) were performed in 96-well Immulon 4 plates (Fisher). For the TNF-␣ ELISA, the murine monoclonal anti-human TNF-␣ antibody clone F12 (Olympus Immunochemicals, Lake Success, N.Y.) was used as the coating antibody and a polyclonal rabbit anti-human TNF-␣ antibody (Genzyme) was used as the capping antibody. The TGF-␤ ELISA was performed with the murine monoclonal anti-human TGF-␤ antibody 12H5 (gift of Genentech) (22) as the coating antibody and a polyclonal chicken anti-human TGF-␤ antibody (R&D Systems, Minneapolis, Minn.) as the capping antibody. Samples were treated with 1 N hydrochloric acid for 30 min and neutralized with NaOH-HEPES before assay. The IL-10 ELISA was performed with a pair of monoclonal anti-human IL-10 antibodies, available from Pharmingen (San Diego, Calif.). Human IL-1␤ and IL-6 were assayed with commercial ELISA kits (R&D Systems).
RESULTS

Induction of TNF-␣, IL-1␤
, and IL-6 by mycobacterial LAM preparations. In preliminary studies, the induction of TNF-␣ in human monocytes by the different preparations of LAM was examined. Monocytes from three donors were stimulated for 24 h with a range of concentrations (0.1, 1, and 10 g/ml) of each LAM. Whereas AraLAM induced TNF-␣ at all concentrations tested, induction was maximal at 10 g/ml. Insignificant TNF-␣ was induced by ManLAM at all concentrations tested; however, induction was best at 10 g/ml (data not shown). Monocytes from a total of nine donors were stimulated with AraLAM, ManLAM, and LPS, each at 10 g/ml, and culture supernatants were harvested at 24 h. AraLAM induced 3.4-fold-greater concentrations of immunoreactive TNF-␣ than did ManLAM (P Ͻ 0.01) (Fig. 1A) . However, AraLAM induced less TNF-␣ than LPS (P Ͻ 0.001). To ensure that altered kinetics of induction of TNF-␣ did not account for the differences seen, monocytes were stimulated for 1, 2, 4, 6, 16, 24, and 48 h with ManLAM or AraLAM. Supernatant TNF-␣ activity remained lower in ManLAM-induced monocyte cultures at all time points (data not shown). In each experiment, TNF-␣ activity in cell lysates was assessed in parallel with cell supernatants to ensure that differences in induction of TNF-␣ were not secondary to differences in compartmentalization of the cytokine. For both LAM preparations, the amount of TNF-␣ in cell lysates at all time points was insignificant and about 1 to 2% of supernatant TNF-␣ activity (data not shown).
Next, the production of IL-1␤ and IL-6 in response to both LAM preparations was analyzed in monocytes cultured from five donors. AraLAM induced from 1.9-to 17.1-fold more IL-1 than did ManLAM (mean fold difference, 8.1) (P Ͻ 0.01). Similarly, AraLAM induced from 1.2-to 4.1-fold more IL-6 (mean fold difference, 2.6) than did ManLAM.
To examine the basis for the differences in cytokine production by the two preparations of LAM, we next assessed the induction of cytokine-specific mRNA in monocyte cultures stimulated with AraLAM, ManLAM, and LPS. The induction of TNF-␣ mRNA by the two LAM preparations was comparable at 3 h and lower than that by LPS (Fig. 1B) . However, steady-state TNF-␣ mRNA levels induced by ManLAM were lower than those with AraLAM and LPS at 24 h of culture. By contrast, the induction of IL-1␤ and IL-6 by ManLAM was minimal at both early (3 h) and late (24 h) time points (Fig. 1C) .
Induction of cytokines by PPD and LAM of M. tuberculosis.
PPD is prepared from a crude autoclaved preparation of the culture filtrate of virulent M. tuberculosis and contains both peptide and nonpeptide mycobacterial antigens. The cytokineinducing capacity of PPD has, however, been attributed in part to its LAM content. We therefore compared the capacity of ManLAM and PPD to induce IL-1 and TNF-␣. The PPD used in these studies had less than 1 g of ManLAM per 100 g of protein, as assessed by Western blot analysis with anti-LAM antibody (Materials and Methods). Monocytes were cultured with ManLAM or PPD at 10 g/ml or in medium alone. Supernatants were collected after 24 h and assessed for TNF-␣ and IL-1 activity. In four experiments, PPD induced significantly more TNF-␣ (4.7-fold, P Ͻ 0.05) and IL-1 (8.8-fold, P Ͻ 0.05) than ManLAM. In parallel, induction of TNF-␣, IL-1, and IL-6 mRNA by PPD was higher than by ManLAM (Fig.  1B and C) .
Induction of IL-10 and TGF-␤ by mycobacterial LAM. We next examined the induction of the anti-inflammatory cytokines IL-10 and TGF-␤ by AraLAM and ManLAM in monocytes. Monocytes were cultured with each preparation of LAM or LPS at 10 g/ml. IL-10 and TGF-␤ were assessed by ELISA in 24-h culture supernatants. Total cellular RNA was assessed for cytokine expression. Both LAM preparations induced IL-10 poorly. Again, AraLAM induced about fivefold-higher amounts of IL-10 than ManLAM (mean, 350 Ϯ 117 pg/ml versus 65 Ϯ 43 pg/ml) (P Ͻ 0.02). The ability of AraLAM to induce IL-10 in monocyte cultures was sixfold lower than that of LPS (P Ͻ 0.02) ( Fig. 2A) . In parallel, the induction of IL-10 mRNA by the two LAM preparations was lower than that by LPS. However, ManLAM was less potent in induction of IL-10 mRNA than AraLAM (Fig. 2B) . On the other hand, the two LAM preparations induced comparable amounts of TGF-␤ protein in culture, which was about 50% of LPS-induced cytokine activity (Fig. 2C) . ManLAM induced TGF-␤ in monocytes by twofold in seven separate experiments (P Ͻ 0.05). Furthermore, in three other experiments, ManLAM extracted from another virulent strain of M. tuberculosis, H37Rv, induced amounts of TGF-␤ similar to those induced by Erdman Man-LAM (1.1 Ϯ 0.3 ng/ml and 1.4 Ϯ 0.4 ng/ml, respectively). The constitutive expression of TGF-␤ mRNA was not affected by either ManLAM or AraLAM (Fig. 2D) .
Effect of ManLAM on induction of cytokines. Most of the biological activity of LAM has been attributed to the phosphatidylinositol end of the molecule, which is identical in AraLAM and ManLAM (4, 13) . Considering the differences in monocyte activation, it was possible, however, that a different structural part of ManLAM was suppressive to the induction of protein synthesis induced by the activating moiety. Recently, mannose receptors have been shown to be important in phagocytosis of the virulent Erdman strain (27) . We speculated that engagement of the mannosyl residues of ManLAM with their respective receptors could potentially lead to a reduction in monocyte activation. To examine this issue, monocytes were cultured in the presence of ManLAM (10 g/ml), AraLAM (10 g/ml), or medium for 1 h at 37ЊC, after which suboptimal concentrations of LPS (0.5 g/ml) were added to cultures. No reduction in subsequent expression of cytokine mRNA (data not shown) or supernatant TNF or IL-1 activity upon stimulation with LPS ( Fig. 3) was apparent. Furthermore, both ManLAM and AraLAM enhanced LPS-induced cytokine production marginally. Similarly, ManLAM pretreatment did not reduce induction of cytokines by AraLAM (data not shown).
DISCUSSION
This study indicates that ManLAM from virulent M. tuberculosis has a lower capacity to activate human monocytes to produce proinflammatory (TNF-␣, IL-1, and IL-6) and some anti-inflammatory (IL-10) cytokines, in contrast to preserved induction of TGF-␤, than the structurally similar but not identical AraLAM from a rapidly growing mycobacterial strain. The differences in cytokine induction by AraLAM and Man-LAM may be attributed to variations in the nonreducing ter- Recently, LAM of the mycobacterial cell wall has been ascribed a major role in host-bacterium interactions and considered a key pathogenic factor (10, 26, 28) . Murine peritoneal macrophages infected with M. leprae or treated with LAM were not responsive to activation by gamma interferon in production of reactive oxygen intermediaries and expression of class II major histocompatibility complex molecules (28) . In parallel, LAM scavenged oxygen radicals, inhibited protein kinase C activity, and restricted gamma interferon-mediated transcriptional activation of human monocytic cell lines (10) . More recently, direct comparisons between ManLAM from the pathogenic Erdman strain and AraLAM have shown a lower induction by the former of the immediate-early genes, such as c-fos, KC, and JE (26) , and TNF-␣ secretion in murine macrophages (13) . Also, in human monocytic cell-line THP-1, AraLAM induced higher concentrations of immunoreactive TNF-␣ and IL-1␤, while cytokine induction by ManLAM was insignificant (36) . Furthermore, it was shown that AraLAM activated THP-1 cells in a manner analogous to LPS, using the LPS receptor CD14 to induce cytokines in whole blood cells (36) . Our studies extend these observations to human monocyte expression of macrophage-activating and -deactivating molecules by LAM. ManLAM induced significantly less TNF-␣ (3.4-fold), IL-1␤ (8.1-fold), and IL-6 (2.6-fold) than AraLAM. In parallel, the induction of IL-1␤ and IL-6 mRNA was significantly lower in ManLAM-stimulated monocyte cultures at early (3 h) and late (24 h) time points. The induction of TNF-␣ mRNA by ManLAM was similar to that by AraLAM at 3 h but significantly less after longer culture (24 h). These differences in the pattern of cytokine responses to ManLAM at early time points of monocyte induction may be due to the sensitivity of expression of the TNF-␣ gene to short-lived repressor proteins (14) , the production of which may be inhibited by ManLAM. Thus, it appears that unlike murine macrophages (26) , in human monocytes, transcriptional activation of early genes such as that for TNF-␣ is not downregulated by ManLAM. Since both transcriptional and posttranscriptional FIG. 3 . Effect of LAM on LPS-stimulated cytokine production in monocytes. Cells were treated with ManLAM (10 g/ml), AraLAM (10 g/ml), or medium for 1 h, and then cultures received LPS at 0.5 U/ml or medium. Culture supernatants were assessed for TNF-␣ (top) and IL-1␤ (bottom) activity at 24 h. Data represent the mean Ϯ SEM of five experiments.
VOL. 64, 1996 INDUCTION OF CYTOKINES BY M. TUBERCULOSIS LAM 403 activation is operative in induction of TNF-␣ (9), the effect of ManLAM on monocytes may be due to inefficient translation of TNF-␣ at early time points. At later time points, however, a defect in transcription of TNF-␣ is superimposed. By contrast, the differences between ManLAM and Ara LAM with regard to induction of the deactivating cytokines IL-10 and TGF-␤ were less marked. Both preparations induced IL-10 mRNA and protein poorly compared with LPS. However, once again, ManLAM induced less protein and mRNA than AraLAM. On the other hand, induction of TGF-␤ by the two LAMs was similar and approximately half of the induction by LPS. Furthermore, ManLAM from a second virulent laboratory strain, H37Rv, was comparable to ManLAM from Erdman strain in induction of TGF-␤. On the other hand, TGF-␤ mRNA was not modulated by ManLAM or AraLAM. Therefore, as with LPS-induced TGF-␤ production (2), induction of TGF-␤ protein by LAM is not due to transcriptional activation. By contrast, PPD of M. tuberculosis induced TGF-␤ transcription (32) .
We found that ManLAM did not suppress the induction of cytokines (IL-1␤ and TNF-␣) in monocytes by LPS or Ara LAM. Furthermore, LPS-induced TNF-␣ and IL-1␤ levels increased marginally and to the same extent when monocytes were pretreated with either ManLAM or AraLAM (Fig. 3) . Since AraLAM may induce monocytes through the LPS-binding molecule CD14, these data may indicate a maximal usage of these receptors by LPS and AraLAM in culture. Alternatively, displacement of AraLAM bound to CD14 by LPS in the second culture could account for these results. However, unlike the suppression of gamma interferon-induced macrophage activation by LAM reported previously (10, 24, 28), we did not find a direct downregulation of monocyte activation, in terms of production of cytokines, by ManLAM. Differences in the amounts of LAM used could underlie these discordant findings. Both LAMs were used at lower amounts (10 g/ml) in this study compared with the 10 to 10,000 g/ml in that by Sibley et al. (28) and Moreno et al. (24) . Furthermore, Molloy et al. found that suppression of T-cell blastogenesis attributed to LAM from M. leprae and M. tuberculosis was due to the presence of LPS in their preparations (23) . The role of Man-LAM in the virulence and pathogenicity of M. tuberculosis is presently uncertain. Clearly, the cell walls of both fully virulent (Erdman and H37Rv) and attenuated (BCG and H37Ra) mycobacteria contain ManLAM (25) . Although mannose capping cannot be the sole determinant of pathogenicity, it may have some role through interactions with other, presumably multiple, virulence determinants. In this regard, the finding that ManLAM retains the capacity to induce TGF-␤, a key immunosuppressive and macrophage-deactivating molecule, is certainly consonant with a role in immunopathogenesis. TGF-␤ induced by ManLAM might, in turn, block T-cell-dependent monocyte activation, thus favoring intracellular bacillary replication.
Since LAM is ubiquitous in mycobacterial preparations, it was important to show that some of the reported monocyteactivating attributes of these preparations, in particular PPD, were not just due to contamination with LAM. The ManLAM content of PPD was less than 1 g/100 g of protein by Western blot analysis. In direct comparison with PPD of virulent M. tuberculosis, ManLAM proved to induce significantly less TNF-␣, IL-1␤, and IL-6 protein and cytokine-specific mRNA. Induction of TNF-␣ by purified antigens of M. tuberculosis, such as the 58-kDa (34) and 30-kDa alpha (3) antigens, is therefore unlikely to be due just to contamination with LAM.
In conclusion, although LAM from M. tuberculosis activates human monocyte cytokines poorly, it is not suppressive of monocyte production of cytokines. On the other hand, the retained ability of ManLAM to induce TGF-␤ may shift the cytokine milieu induced by M. tuberculosis and its components to one of macrophage deactivation in situ and thereby promote survival of the organism.
